✦ LIBER ✦

The triple neurokinin-receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma

✍ Scribed by V. Schelfhout; R. Louis; W. Lenz; R. Heyrman; R. Pauwels; G. Joos

Book ID: 116853230
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 201 KB
Volume: 19
Category: Article
ISSN: 1094-5539
DOI: 10.1016/j.pupt.2005.10.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel triple neurokinin receptor antagon

Novel triple neurokinin receptor antagonist CS-003 inhibits respiratory disease models in guinea pigs

✍ Hiroshi Tsuchida; Sakiko Takahashi; Emi Nosaka; Takako Kuraya; Makoto Yamashita; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 641 KB

Neurokinin-receptor antagonist inhibits

Neurokinin-receptor antagonist inhibits bradykinin-induced bronchoconstriction and cough in asthmatic patients

✍ M. Ichinose; N. Nakajima; T. Takahashi; H. Yamauchi; H. Inoue; K. Shirato; T. Ta 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Protection against bradykinin-induced br

Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist

✍ Inoue, H.; Takishima, T.; Ichinose, M.; Nakajima, N.; Takahashi, T.; Yamauchi, H 📂 Article 📅 1992 🏛 The Lancet 🌐 English ⚖ 518 KB

The effect of the leukotriene receptor a

The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma—A comparison with leukotriene D4 induced broncoconstriction

✍ V. Schelfhout; V. Van De Velde; R. Pauwels; G. Joos 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 225 KB

Phase 2 trial results with the novel neu

Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy

✍ Wichit Arpornwirat; Istvan Albert; Vincent L. Hansen; Jeremey Levin; Rajesh R. B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

Efficacy and safety of casopitant mesyla

Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial

✍ Steven M Grunberg; Janusz Rolski; Janos Strausz; Zeba Aziz; Stephen Lane; Mark W 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 251 KB